logo

Einzelheiten zu den Produkten

Created with Pixso. Zu Hause Created with Pixso. Produits Created with Pixso.
Infektionskrankheits-Prüfung
Created with Pixso.

IRSC-502 -- RSV and SARS-CoV-2 Antigen Combo Rapid Test (Nasopharyngeal Swab)

IRSC-502 -- RSV and SARS-CoV-2 Antigen Combo Rapid Test (Nasopharyngeal Swab)

Markenbezeichnung: ALLTEST
Modellnummer: IRSC-502
Einzelheiten
Herkunftsort:
CHINA
Zertifizierung:
CE
Genauigkeit:
RSV: 96,1 % SARS-CoV-2: 98,2 %
Zeit zum Lesen:
15 Minuten
Speicherbedingungen:
2 bis 30°C
OEM:
Verfügbar
Test-Ausrüstung:
10t
Format:
Kassette
Exemplare:
Nasenrachenraumputzlappen
Beschreibung des Produkts

The RSV and SARS-CoV-2 Antigen Combo Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of RSV and SARS-CoV-2 infectious diseases in human nasopharyngeal swab specimens as an aid in the diagnostic of RSV and SARS-CoV-2 infectious diseases.

 

RSV (Respiratory Syncytial Virus) and SARS-CoV-2 (the virus that causes COVlD-19) areboth highly contagious respiratory viruses, but they affect populations differently. RSV isa leading cause of severe respiratory illness in infants and older adults, while SARS-CoV-2has caused a global pandemic affecting all age groups. Symptoms of RSV often resemblea common cold but can escalate to bronchiolitis or pneumonia, characterized by severecough, wheezing, and difficulty breathing. In contrast, SARS-CoV-2 infection (COVID-19)presents with a wider range of symptoms, including fever, cough, fatigue, and loss ottaste or smell. While many cases are mild, it can lead to severe pneumonia, acute respira-tory distress syndrome (ARDS), and systemic complications.

 

Product Advantages:
Fast Results in 15 Minutes
High Accuracy
Easy Visual Interpretation
Convenient Procedure

 

Format Cassette Specimen Nasopharyngeal Swab
Certificate CE Reading Time 15 minutes
Storage Temperature 2-30°C Sensitivity RSV: 93.2% SARS-CoV-2: 96.4%
Specificity RSV: 98.1% SARS-CoV-2: 99.0% Accuracy RSV: 96.1% SARS-CoV-2: 98.2%
Pack 10 T